Fibrocell Science, Inc. Reports First Quarter 2014 Financial And Operating Results

Fibrocell Science, Inc. (NYSE MKT: FCSC), an autologous cell therapy company primarily focused on developing first-in-class treatments for rare and serious skin and connective tissue diseases with high unmet medical needs, today reported financial results for the first quarter of 2014. The company will host a conference call and webcast at 5:00 p.m. EDT, today.

Help employers find you! Check out all the jobs and post your resume.